Efficacy and safety of concizumab prophylaxis in patients with haemophilia and inhibitors: Results from the Early Access Program in France
Authors:
Alexandre Butelet1; Nicolas Béranger2; Vincent Cussac2; Roseline d’Oiron3-6; Yesim Dargaud4-5; Victoria Delerue2; Stéphanie Desage5; Caroline Galeotti3; Sophie Susen7; Valérie Chamouard4-5